Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 7, 2007, Pages 795-798

  Lecleire Collet, Amélie ^a   Offret, Olivier ^a   Gaucher, David ^a   Audren, François ^a   Haouchine, Belkacem ^a   Massin, Pascale ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Diabetic macular edema; Full thickness macular hole; Intravitreal triamcinolone acetonide injection; Retinal thinning

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; CELL DAMAGE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EPIRETINAL MEMBRANE; FEMALE; HUMAN; LASER COAGULATION; MUELLER CELL; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; PSEUDOCYST; RECURRENT DISEASE; RETINA DETACHMENT; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; RETINA MACULA HOLE; VISUAL ACUITY; VITRECTOMY;

DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA; MIDDLE AGED; RETINA; RETINAL PERFORATIONS; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY;

EID: 35449006330     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00925.x     Document Type: Article

References (15)

1. Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudric A & Massin P (2006): Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial. Acta Ophthalmol Scand 84: 624-630.
2. Brazitikos PD & Stangos NT (1999): Macular hole formation in diabetic retinopathy: The role of coexisting macular edema. Doc Ophthalmol 97: 273-278.
3. Chu TG, Lopez PF, Cano MR, Freeman WR, Lean JS, Liggett PE, Thomas EL & Green RL (1996): Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology 103: 315-322.
4. Gaudric A, Haouchine B, Massin P, Paques M, Blain P & Erginay A (1999): Macular hoNe formation: new data provided by optical coherence tomography. Arch Ophthalmol 117: 744-751.
5. Ghoraba H (2002): Types of macular holes encountered during diabetic vitrectomy. Retina 22: 176-182.
6. Jonas JB (2005): Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand 83: 645-663.
7. Magarinos AM & McEwen BS (1995): Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69: 89-98.
8. Massin P, Girach A, Erginay A & Gaudric A (2006): Optical coherence tomography: A key to the future management of patients with diabetic macular oedema. Acta Ophthalmol Scand 84: 466-474.
9. Oehrens AM & Stalmans P (2006): Optical coherence tomographic documentation of the formation of a traumatic macular hole. Am J Ophthalmol 142: 866-869.
10. Ozdemir H, Karacorlu M & Karacorlu S (2005): Resolution of foveal pseudocyst after intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 83: 619-620.
11. Sivaprasad S, McCluskey P & Lightman S (2006): Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand 84: 722-733.
12. Sorensen TL, Haamann P, Villumsen J & Larsen M (2005): Intravitreal triamcinolone for macular oedema: Efficacy in relation to aetiology. Acta Ophthalmol Scand 83: 67-70.
13. Spaide RF (2005): Macular hole hypotheses. Am J Ophthalmol 139: 149-151.
14. Vinten M, Larsen M, Lund-Andersen H, Sander B & La Cour M (2007): Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema. Acta Ophthalmol Scand 85: 21-26.
15. Yoon KC & Seo MS (2003): Macular hole after peeling of the internal limiting membrane in diabetic macular edema. Ophthalmic Surg Lasers Imaging 34: 478-479.